BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30015977)

  • 1. Overexpression of miR‑221 and miR‑222 in the cancer stroma is associated with malignant potential in colorectal cancer.
    Iida M; Hazama S; Tsunedomi R; Tanaka H; Takenouchi H; Kanekiyo S; Tokumitsu Y; Tomochika S; Tokuhisa Y; Sakamoto K; Suzuki N; Takeda S; Ueno T; Yamamoto S; Yoshino S; Fujita K; Kuroda M; Nagano H
    Oncol Rep; 2018 Sep; 40(3):1621-1631. PubMed ID: 30015977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenascin C in colorectal cancer stroma is a predictive marker for liver metastasis and is a potent target of miR-198 as identified by microRNA analysis.
    Murakami T; Kikuchi H; Ishimatsu H; Iino I; Hirotsu A; Matsumoto T; Ozaki Y; Kawabata T; Hiramatsu Y; Ohta M; Kamiya K; Fukushima M; Baba S; Kitagawa K; Kitagawa M; Konno H
    Br J Cancer; 2017 Oct; 117(9):1360-1370. PubMed ID: 29065427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
    Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A
    Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on Survival.
    Pecqueux M; Liebetrau I; Werft W; Dienemann H; Muley T; Pfannschmidt J; Müssle B; Rahbari N; Schölch S; Büchler MW; Weitz J; Reissfelder C; Kahlert C
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying metastasis-initiating miRNA-target regulations of colorectal cancer from expressional changes in primary tumors.
    Lee J; Hong HK; Peng SB; Kim TW; Lee WY; Yun SH; Kim HC; Liu J; Ebert PJ; Aggarwal A; Jung S; Cho YB
    Sci Rep; 2020 Sep; 10(1):14919. PubMed ID: 32913235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.
    Toiyama Y; Hur K; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    Ann Surg; 2014 Apr; 259(4):735-43. PubMed ID: 23982750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
    Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-associated stroma reveals prognostic biomarkers and novel insights into the tumour microenvironment of colorectal cancer and colorectal liver metastases.
    Brown KM; Xue A; Smith RC; Samra JS; Gill AJ; Hugh TJ
    Cancer Med; 2022 Jan; 11(2):492-506. PubMed ID: 34874125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
    Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
    Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
    Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma.
    Zhang Y; Pan J; Xu D; Yang Z; Sun J; Sun L; Wu Y; Qiao H
    Oncol Rep; 2018 Dec; 40(6):3611-3624. PubMed ID: 30542708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs.
    Bullock MD; Pickard K; Mitter R; Sayan AE; Primrose JN; Ivan C; Calin GA; Thomas GJ; Packham GK; Mirnezami AH
    Oncotarget; 2015 Mar; 6(9):7262-79. PubMed ID: 25788261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
    Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
    Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential microRNA expression profiling in primary tumors and matched liver metastasis of patients with colorectal cancer.
    Li W; Chang J; Tong D; Peng J; Huang D; Guo W; Zhang W; Li J
    Oncotarget; 2017 May; 8(22):35783-35791. PubMed ID: 28415758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of differential miRNA expression with hepatic vs. peritoneal metastatic spread in colorectal cancer.
    Heublein S; Albertsmeier M; Pfeifer D; Loehrs L; Bazhin AV; Kirchner T; Werner J; Neumann J; Angele MK
    BMC Cancer; 2018 Feb; 18(1):201. PubMed ID: 29463215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.
    Hur K; Toiyama Y; Okugawa Y; Ide S; Imaoka H; Boland CR; Goel A
    Gut; 2017 Apr; 66(4):654-665. PubMed ID: 26701878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases.
    Zeng ZS; Cohen AM; Zhang ZF; Stetler-Stevenson W; Guillem JG
    Clin Cancer Res; 1995 Aug; 1(8):899-906. PubMed ID: 9816060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of microRNA-487b as a negative regulator of liver metastasis by regulation of KRAS in colorectal cancer.
    Hata T; Mokutani Y; Takahashi H; Inoue A; Munakata K; Nagata K; Haraguchi N; Nishimura J; Hata T; Matsuda C; Murata K; Mizushima T; Doki Y; Mori M; Yamamoto H
    Int J Oncol; 2017 Feb; 50(2):487-496. PubMed ID: 28000854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray analysis reveals that high mobility group A1 is involved in colorectal cancer metastasis.
    Takahashi Y; Sawada G; Sato T; Kurashige J; Mima K; Matsumura T; Uchi R; Ueo H; Ishibashi M; Takano Y; Akiyoshi S; Eguchi H; Sudo T; Sugimachi K; Tanaka J; Kudo SE; Doki Y; Mori M; Mimori K
    Oncol Rep; 2013 Sep; 30(3):1488-96. PubMed ID: 23835740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.